CoChat

The DOI matches its Crossref record; 134 of the 134 references it cites were found in a registry or an index.

Drug repurposing to overcome resistance to various therapies for colorectal cancer

Open access
Fong, Winnie, To, Kenneth K. W. · 2019 · Cellular and Molecular Life Sciences

Abstract

Emergence of novel treatment modalities provides effective therapeutic options, apart from conventional cytotoxic chemotherapy, to fight against colorectal cancer. Unfortunately, drug resistance remains a huge challenge in clinics, leading to invariable occurrence of disease progression after treatment initiation. While novel drug development is unfavorable in terms of time frame and costs, drug repurposing is one of the promising strategies to combat resistance. This approach refers to the application of clinically available drugs to treat a different disease. With the well-established safety profile and optimal dosing of these approved drugs, their combination with current cancer therapy is suggested to provide an economical, safe and efficacious approach to overcome drug resistance and prolong patient survival. Here, we review both preclinical and clinical efficacy, as well as cellular mechanisms, of some extensively studied repurposed drugs, including non-steroidal anti-inflammatory drugs, statins, metformin, chloroquine, disulfiram, niclosamide, zoledronic acid and angiotensin receptor blockers. The three major treatment modalities in the management of colorectal cancer, namely classical cytotoxic chemotherapy, molecular targeted therapy and immunotherapy, are covered in this review.

Overview

Integrity signals

Registry

Crossref · 10.1007/s00018-019-03134-0

Cites

134 of 134 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 134 references

Research works printed but not linked: 1

  1. Du B, Guo Y, Jin L, Xiong M, Liu D, Xi X (2017) Targeting autophagy promote the 5-fluorouracil induced apoptosis in human colon cancer cells. Int J Clin Exp Pathol 10:6071–6081

Cited by

See all 81

Metadata

Authors
Fong, W., & To, K. K. W.
Affiliations
Chinese University of Hong Kong (HK)
Corresponding author
To, Kenneth K. W.
Venue
Cellular and Molecular Life Sciences
Published
2019-05-13
Volume
76
Issue
17
Pages
3383-3406
ISSN
  • 1420-682X (ISSN-L)
  • 1420-9071
OpenAlex
W2946262777
Cited by
81
References
134
Citations by year
2026: 3 · 2025: 5 · 2024: 15 · 2023: 10 · 2022: 12 · 2021: 17 · 2020: 8 · 2019: 10
FWCI
1.12
Type
journal article
Language
en
Open access
Licence
Locations
  • Cellular and Molecular Life Sciences (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Health and Medical Research Fund (03140276)
  • Medicine Panel of the Chinese University of Hong Kong (Direct Grant for Research 4054371)
Topics
  • Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer therapeutics and mechanisms
Keywords
drug repurposing, colorectal cancer, drug resistance, nonsteroidal anti-inflammatory drugs, statins, metformin, chloroquine, disulfiram, niclosamide, zoledronic acid, angiotensin receptor blockers, cytotoxic chemotherapy, targeted therapy, immunotherapy
MeSH terms
Antineoplastic Agents, Immunological, Anti-Inflammatory Agents, Non-Steroidal, Antimetabolites, Antineoplastic Agents, Humans, Colorectal Neoplasms, Drug Resistance, Neoplasm, Protein Kinase Inhibitors, Drug Repositioning, Topoisomerase I Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Drug repurposing to overcome resistance to various therapies for colorectal cancer. https://app.cochat.ai/papers/10.1007/s00018-019-03134-0
The paper
Fong, W., & To, K. K. W. (2019). Drug repurposing to overcome resistance to various therapies for colorectal cancer. Cellular and Molecular Life Sciences. https://doi.org/10.1007/s00018-019-03134-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.